ArticleHealthcare (Basel, Switzerland)2022
Public Health Financing and Responses to COVID-19: Lessons from South Korea.
Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Enhancing financial stability in healthcare through data-driven risk assessments with machine learning.Scientific reports · 2026Article
- Challenges in Planning the Hospital Nursing Workforce Under the Government-Led Response to COVID-19 in South Korea: A Descriptive, Qualitative Study.Journal of advanced nursing · 2025Article
- The Silent Risk of Sudan Virus: A Review Addressing Global Health Vulnerabilities.Health science reports · 2025Article
- Natural disaster emergency response from a public policy perspective: a four-party evolutionary game among government, international organizations, healthcare institutions, and enterprises.Frontiers in public health · 2025Article
- Toward better pandemic governance and preparedness: South Korea's whole-of-nation approach to COVID-19.BMC public health · 2024Article
- The Hand, Foot, and Mouth Disease Sentinel Surveillance System in South Korea: Retrospective Evaluation Study.JMIR public health and surveillance · 2024Article
- Economic impact of government health expenditure: An application of the computable general equilibrium model to the Iran.Journal of education and health promotion · 2024Article
- The COVID-19 endemic in Vietnam: Contextual considerations and implications.Frontiers in public health · 2023Article
- Riding the Pandemic Waves-Lessons to Be Learned from the COVID-19 Crisis Management in Romania.Tropical medicine and infectious disease · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Health financing strategies contribute significantly to containing the outbreak of the Coronavirus disease 2019 (COVID-19). This study aims to reassess Korea's financing strategies in response to COVID-19 in 2020, to ascertain its effects and sustainability. The Joint External Evaluation tool was adopted to analyze the data collected from government reports, official statistics, and other sources. Findings show that Korea could maintain a low incidence and fatality rate compared with other countries, at low costs. It was a result of rapidly procured healthcare resources based on laws and policies established after the 2015 epidemic, and the National Health Insurance. However, to achieve long-term sustainability, it is important to enhance the financial stability of the national health insurance and increase the proportion of the public sector in healthcare resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.